Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities
Net (loss) income	$ (2,807)	$ 42,962
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation, amortization and accretion	14,615	11,786
Impairment of long-lived assets	132,052	0
Asset retirement obligation acceleration	0	293
Amortization of debt related costs	1,082	246
Changes in fair value of contingent assets and liabilities	(1,400)	18,400
Provision for excess and obsolete inventory	680	2,519
Stock-based compensation	9,667	5,623
Deferred taxes	(35,863)	14,180
Long-term indemnification receivable	(96)	(396)
Long-term income tax payable and other long-term liabilities	123	779
Other	1,225	829
(Decreases) increases in cash from operating assets and liabilities:
Accounts receivable	(24,681)	(85,155)
Inventory	(7,124)	(1,634)
Other current assets	2,479	(104)
Other long-term assets	0	(533)
Accounts payable	6,747	1,506
Accrued expenses and other liabilities	11,801	(1,037)
Net cash provided by operating activities	108,500	10,264
Investing activities
Capital expenditures	(9,168)	(3,190)
Proceeds from sale of assets, net	0	1,800
Acquisition of assets, net	(35,345)	0
Net cash used in investing activities	(44,513)	(1,390)
Financing activities
Payments on long-term debt and other borrowings	(297)	(2,609)
Proceeds from stock option exercises	1,842	5,357
Proceeds from issuance of common stock	940	577
Payments for minimum statutory tax withholding related to net share settlement of equity awards	(11,154)	(5,504)
Net cash used in financing activities	(8,669)	(2,179)
Effect of foreign exchange rates on cash, cash equivalents and restricted cash	(98)	151
Net increase in cash, cash equivalents and restricted cash	55,220	6,846
Cash, cash equivalents and restricted cash, beginning of period	417,241	100,651
Cash, cash equivalents and restricted cash, end of period	472,461	107,497
Reconciliation to amounts within the condensed consolidated balance sheets
Cash and cash equivalents	470,863	105,355
Restricted cash included in other long-term assets	1,598	2,142
Cash, cash equivalents and restricted cash at end of period	$ 472,461	$ 107,497